Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dose response studies. II. Analysis and interpretation

S J Ruberg1

  • 1Marion Merrell Dow Inc., Kansas City, Missouri 64134-0627, USA.

Journal of Biopharmaceutical Statistics
|March 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Paradigm shifts in clinical trials enabled by information technology.

Statistics in medicine·2001
Same author

Detecting dose response with contrasts.

Statistics in medicine·2000
Same author

Randomization tests for assessing the equality of area under curves for studies using destructive sampling.

Journal of applied toxicology : JAT·1996
Same author

Factorial dose-response studies using frequency and magnitude of dose.

Journal of biopharmaceutical statistics·1996
Same author

Dose response studies. I. Some design considerations.

Journal of biopharmaceutical statistics·1995
Same author

Applicability of teicoplanin dosage adjustment guidelines for renally impaired patients over the range of 3 to 30 mg kg-1.

Biopharmaceutics & drug disposition·1992
Same journal

Correction.

Journal of biopharmaceutical statistics·2026
Same journal

Leveraging external controls in clinical trials: estimands, estimation, assumptions.

Journal of biopharmaceutical statistics·2026
Same journal

Special issue of nonclinical statistics in regulatory applications guest editors' notes.

Journal of biopharmaceutical statistics·2026
Same journal

Comparison of flexible parametric modeling and nonparametric methods to estimate restricted mean survival time: A simulation study.

Journal of biopharmaceutical statistics·2026
Same journal

Simulated treatment comparisons with jackknife pseudo values for estimating population-adjusted marginal treatment effects.

Journal of biopharmaceutical statistics·2026
Same journal

Sample sizes for randomized controlled trials utilizing Bayesian response adaptive randomization for continuous outcomes.

Journal of biopharmaceutical statistics·2026
See all related articles

This study reviews methods for analyzing dose-response studies in drug development, focusing on finding the minimum effective dose. ANOVA is preferred for fewer dose groups, while regression models are better for more groups.

Area of Science:

  • Pharmaceutical research
  • Biostatistics
  • Drug development

Background:

  • Dose-response studies are crucial in pharmaceutical drug development.
  • Identifying the minimum effective dose is a key objective.
  • Standard analysis strategies are needed for these studies.

Purpose of the Study:

  • To examine analysis strategies for parallel, randomized dose-response studies.
  • To emphasize the identification of the minimum effective dose.
  • To compare ANOVA and regression models for dose-response analysis.

Main Methods:

  • Focus on Analysis of Variance (ANOVA) with multiple comparison procedures.
  • Discussion of the utility of regression models.
  • Review of analysis for factorial dose-response studies.

Related Experiment Videos

Main Results:

  • ANOVA techniques are preferred for studies with three or fewer dose groups and a placebo.
  • Regression analysis offers greater utility and reliability with a larger number of dose groups.
  • Factorial dose-response study analysis is an emerging area requiring further development.

Conclusions:

  • The choice of analysis method (ANOVA vs. regression) depends on the number of dose groups.
  • ANOVA is suitable for simpler study designs, while regression is more robust for complex ones.
  • Further research is needed for advanced study designs like factorial dose-response studies.